GPT and anemia (phenotype): In addition, one patient in Part B reported treatment‐related Grade ≥3 TEAE of neutrophil count decreased, platelet count decreased, white blood cell count decreased, anemia, ALT increased, and AST increased, all of which except AST increased were observed in the patients treated with merestinib, gemcitabine, and cisplatin in the global study as treatment‐related Grade ≥3 TEAE.